Скачать или смотреть Women’s Health Update – October 15, 2025: UZEDY expansion, Breast Cancer, Alzheimer’s Test and More

This episode of Women’s Health Update brings fast, credible insights—from bipolar treatment advancements to multiple sclerosis therapies, Alzheimer’s diagnostics, and more!

🔬 Key highlights:

💊 FDA expands UZEDY (risperidone) to maintenance in adult bipolar I

💰 Women’s Health Fund targets market-building at scale

🩺 Novartis survey: breast health conversations remain constrained

💊 Gilead delays US Biktarvy generics to 2036 via settlements

🤝 Zenas licenses orelabrutinib and 2 assets from InnoCare, raises $120M

💊 Datopotamab deruxtecan hits OS and PFS in 1L TNBC (TROPION-Breast02)

💊 BioNxt files US Track One patent for sublingual cladribine (MS)

🧠 WHO Foundation and Lilly collaborate on global dementia plan

💉 FDA clears Roche–Lilly Elecsys pTau181 blood test for Alzheimer’s aid

🎗️ Lobular breast cancer incidence rising faster than other types

🧬 Study: higher genetic risk burden for depression in women

📢 Stay Ahead in Women’s Health Research!
✅ Like, share, and subscribe for our updates on Women’s Health
✅ Visit www.lqventures.com for expert healthcare insights and consulting services.
✅ Contact LucidQuest at [email protected] for strategic guidance on Women’s Health innovations and clinical research.
🔔 Turn on notifications so you never miss an update!

#WomensHealth #BipolarDisorder #Alzheimers #BreastCancer #TripleNegativeBreastCancer #MS #MultipleSclerosis #Depression #Biopharma #FDAApprovals #HealthTech #ClinicalTrials #LucidQuest #WomenInScience #MedicalResearch #DrugDevelopment